Andrew M. Goldstein

Pulmonary Medicine

170 Maple Ave Ste 208
White Plains, NY 10601

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study.

Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study.

Journal: Autoimmune diseases

Published: October 06, 2011

Showing 1-1 of 1

Last Updated: 09/26/2026